Communication:
Mass communication is a deal with in which a person, organise of community, or an organization addresses a message through a channel of communication to a large group of anonymous and heterogeneous society and organizations. You can think of a broad group of anonymous and heterogeneous society as either the general society or a segment of the general public. Channels of communication combine broadcast television,
radio, social media, and print. The sender of the message is usually an experienced communicator that often represents an institution. Mass communication is a high process. Unlike interpersonal communication, feedback for
mass communication is commonly easy and indirect.
Mass communication is a course in which a person, group of people, or an organization sends a message through a medium of communication to a large group of anonymous and heterogeneous society and organizations. ... Channels of communication have broadcast television,
radio, social media, and print.
High Impact List of Articles
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Evaluation of Edible Oyster Mushroom (Pleurotus ostreatus) on Oxidative Stress and Neurological Cognitive Disorder in Streptozotocin-Diabetic Rats
Bindhu J and Arunava Das
Research Paper: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
The emerging role of vedolizumab in the treatment of ulcerative colitis
Mahmoud H Mosli, Brian G Feagan
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Why antidepressant clinical trials fail: the role of expectations
Mark Sinyor, Ayal Schaffer, Anthony J Levitt
Editorial: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
Relevant Topics in Clinical